
Awnacef SB 250mg/125mg Injection
Marketer
Shawn & Co
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Awnacef SB 250mg/125mg Injection
Cefixime and Sulbactam injection (250mg/125mg), a dual-action antibiotic, combats various bacterial infections by inhibiting microbial proliferation. Administration must be under a doctor's direct supervision; complete the prescribed course regardless of symptom improvement to ensure efficacy. Premature cessation may reduce effectiveness. Potential side effects include nausea, vomiting, diarrhea, and indigestion. Severe reactions necessitate immediate medical attention. Allergic responses (rash, itching, swelling, breathing difficulties) require emergency care. Inform your physician of all current medications, including those for pre-existing conditions, before commencing treatment. This is crucial for pregnant or breastfeeding individuals. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, refrain from driving if drowsiness or dizziness occur. Adequate rest, a balanced diet, and sufficient hydration are recommended for optimal recovery. Your doctor might order blood tests and other examinations to monitor the drug's effects.
Primary Ingredients of Awnacef SB 250mg/125mg Injection
No text provided. Please provide the text you want me to rephrase.
Uses of Awnacef SB 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Awnacef SB 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Awnacef SB 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Awnacef SB 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Awnacef SB 250mg/125mg Injection works:
Ceftriaxone and Sulbactam, combined as Awnacef SB 250mg/125mg Injection, offer a dual antibiotic approach. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Sulbactam, a beta-lactamase inhibitor, counters bacterial resistance mechanisms, thereby optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Awnacef SB 250mg/125mg Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Awnacef SB, 250mg/125mg, is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; yet, data from human trials are scarce.
Breast feedingCAUTION
The use of Awnacef SB 250mg/125mg Injection while breastfeeding requires careful consideration. Mothers should discontinue breastfeeding throughout their treatment course and until the medication is fully cleared from their system.
DrivingUNSAFE
The injection Awnacef SB 250mg/125mg can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Awnacef SB 250mg/125mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable medication Awnacef SB 250mg/125mg requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for Awnacef SB 250mg/125mg Injection is unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Awnacef SB 250mg/125mg Injection :
Should you forget a dose of Awnacef SB 250mg/125mg Injection, seek your physician's advice.
Facts to Know About Awnacef SB 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
